Cervical adenocarcinoma in young women: Possible relationship to microglandular hyperplasia and use of oral contraceptives

American Journal of Obstetrics and Gynecology

Volumn 73, Issue 6, 1989, Pages 984-989

  Jones, M W ^a   Silverberg, S G ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; HYPERPLASIA; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CERVIX NEOPLASMS; CERVIX UTERI; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL; FEMALE; HUMAN; HYPERPLASIA; MIDDLE AGE; TIME FACTORS;

EID: 0024310002     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1097/00006250-198906000-00015     Document Type: Article

References (21)

1. Dallenbach-Hellweg G. Vorkommen und histologische Struktur des Adenokarzinoms der Zervixschleimhaut nach langjahriger Einnahme von Ovulationshemmern. Geburtshilfe Fraunheilkd 1982;42:249–55.
2. Dallenbach-Hellweg G. On the origin and histologic structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 1984;179:38–50.
3. Davis JR, Moon LB. Increased incidence of adenocarcinoma of the uterine cervix. Obstet Gynecol 1975;45:79–83.
4. Ireland D, Hardemen P, Monaghan JM. Adenocarcinoma of the uterine cervix: A study of 73 cases. Obstet Gynecol 1985;65:82–5.
5. Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423–8.
6. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045–7.
7. Shingleton HM, Gore H, Bradley B, et al. Adenocarcinoma of the cervix. Am J Obstet Gynecol 1981;139:799–814.
8. Tamimi HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335–44.
9. Tasker TJ, Collins JA. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 1974;118:344–58.
10. Valente PT, Hanjani P. Endocervical neoplasia in long-term users of oral contraceptives: Clinical and pathologic observations. Obstet Gynecol 1986;67:695–704.
11. Takahashi M, Aoki K, Noda S, Bonham DG, McLean MR. Some effects of long-term use of oral contraceptives on cervical neoplasia. Int Cong Ser 1984;644:21–7.
12. Czemobilsky B, Kessler I, Lancet M. Cervical adenocarcinoma in a woman on long term contraceptives. Obstet Gynecol 1974;43: 517–21.
13. Gallup DG, Abell MR. Invasive adenocarcinoma of the uterine cervix. Obstet Gynecol 1977;49:596–603.
14. Qizilbash AH. In-situ and microinvasive adenocarcinoma of the uterine cervix. Am J Clin Pathol 1975;64:155–70.
15. Leslie KO, Silverberg SG. Microglandular hyperplasia of the cervix: Unusual clinical and pathologic presentations and their differential diagnosis. Progr Surg Pathol 1984;5:95–114.
16. Nichols TM, Fiedler HK. Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology. Am J Clin Pathol 1971;56:424–9.
17. Friedell GH, McKay DG. Adenocarcinoma in situ of the endocervix. Cancer 1953;6:887–97.
18. Weisbrot IM, Stabinsky C, Davis AM. Adenocarcinoma-in-situ of the uterine cervix. Cancer 1972;29:1179–87.
19. Jaworski RC, Pacey NF, Greenberg ML, Osborn RA. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Cancer 1988;61:1171–81.
20. Tase T, Okagaki T, Clark BA. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: A study by in situ DNA hybridization. Cancer Res 1988;48:993–8.
21. Glucksmann A, Cherry CP. Incidence, histology and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer 1956;9:971–9.